Cases & Deals

Productos Medix shareholders advised in sale of 34% of capital stock to WAMEX Private Equity

Clients Productos Medix, S.A. de C.V.

Jones Day advised Dialicels, S.A. de C.V. as shareholders of Productos Medix, S.A. de C.V., a pharmaceutical company that develops medicines and treatments for patients with overweight and obesity conditions, in connection with the sale of 34% of the capital stock of Productos Medix, S.A. de C.V. to WAMEX Private Equity.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.